Delivery Order SPE2DB22D1017-SPE2DB25FG1DK

Award Date 4/28/25
Potential Completion Date 5/19/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D2018|SPE2DB25FWUH1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orgovyx 120 mg tablets. The contract has a ceiling value of $1,385.52 and a period of performance through May 19, 2025. This appears to be a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,771.04, is for the delivery of the prescription medication Orgovyx 120 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 16, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award, valued at $1,385.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the medication Orgovyx 120 mg tablet, with an ultimate completion date of May 20, 2025. The contract is not set aside and is a firm fixed-price type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award, with an ID of SPE2DB20D3101 and SPE2DB25FRDK3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,771.04 delivery order contract is for the supply of the prescription medication Orgovyx 120 mg tablets. This contract is not designated as a set-aside award. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the prescription drug Orgovyx 120 mg tablets. The contract has a ceiling value of $1,329.89 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the delivery of the prescription drug Orgovyx 120 mg tablets. The contract has a ceiling value of $2,659.78 and a period of performance through July 30, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation,...
This contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is for the delivery of 120 mg Orgovyx tablets. The contract has a firm fixed price of $3,989.67 and a completion date of February 21, 2024. It was awarded on January 30, 2024 as a delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the prescription drug Orgovyx in 120mg tablets. The $4,156.56 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) and has a period of performance through March 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,385.52 for the provision of the drug Orgovyx 120 mg tablets. The contract is under the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product Orgovyx 120 mg Tablet, with a ceiling value of $7,979.34 and a period of performance through May 24, 2024. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG1DK
    Delivery Order

This federal contract award, identified as SPE2DB22D1017|SPE2DB25FG1DK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Orgovyx 120 mg tablets, with a ceiling value of $1,385.52 and a completion date of May 19, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not set aside for any specific business category.

AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:16 AM